文献速递术前评估与围术期医学区域麻醉与超声疼痛医学

美国六医院体系术中多模式镇痛实践与方案差异的横断面研究

Variations in Current Practice and Protocols of Intraoperative Multimodal Analgesia: A Cross-Sectional Study Within a Six-Hospital US Health Care System.
PubMed 文献 · Anesth Analg · 2024-10-25

该横断面研究纳入2017至2022年美国6家相似医院全身麻醉手术患者,发现46.9%的病例符合多模式镇痛定义,使用率年均增长3.0%,但医院间(25.9%-68.6%)和麻醉医师间(IQR 29.8%-65.8%)存在显著差异,且患者和手术特征影响使用。

要点

  • 多模式镇痛使用率逐年上升,年均增长3.0%。
  • 医院间和麻醉医师间使用率差异显著。
  • 常见方案为对乙酰氨基酚联合区域麻醉或地塞米松。

核心结论

  • 在大型整合医疗系统中约半数非心脏手术患者接受多模式镇痛,但患者、手术、医院及麻醉医师间存在广泛差异,需进一步研究以指导安全有效推广。

研究设计与样本

  • 多模式镇痛定义为阿片类药物联用至少2种其他非阿片类镇痛药,数据来自围术期信息管理系统。

主要发现

  • 总体46.9%的病例符合多模式镇痛定义。
  • 接受多模式镇痛者更可能为较年轻女性、合并症负担较低、接受较长且更复杂手术并包括住院。
  • 多模式镇痛使用率自2017年以来平均每年增长3.0%(95%CI 2.6%-3.3%)。
  • 医院间使用率范围25.9%-68.6%(χ²=3774.9,P<.001),麻醉医师间IQR 29.8%-65.8%(χ²=1938.5,P<.001)。
  • 最常见方案为对乙酰氨基酚联合区域麻醉(13.0%)或对乙酰氨基酚联合地塞米松(12.2%)。

关键数值与推荐

  • 多模式镇痛定义:阿片类药物联用至少2种其他非阿片类镇痛药。
  • 研究期间术前或术中阿片类药物使用从91.4%降至86.0%。
  • 对乙酰氨基酚使用从41.9%增至70.5%(P<.001)。
  • 地塞米松使用从24.0%增至36.1%(P<.001),非甾体抗炎药从6.9%增至17.3%(P<.001)。
  • 加巴喷丁类药物和静脉利多卡因使用较少但也增加(分别0.8%-1.6%和3.4%-5.3%,P<.001)。

临床怎么用

  • 临床可参考常见多模式镇痛方案如对乙酰氨基酚联合区域麻醉或地塞米松。
  • 需关注医院和麻醉医师间的实践差异,促进安全有效采用多模式镇痛。

局限性

  • 研究为横断面设计,仅能揭示关联而非因果。
  • 结果基于美国6家地理相似医院,外推性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multimodal analgesia (MMA) aims to reduce surgery-related opioid needs by adding nonopioid pain medications in postoperative pain management. In light of the opioid epidemic, MMA use has increased rapidly over the past decade. We hypothesize that the rapid adoption of MMA has resulted in variation in practice. This cross-sectional study aimed to determine how MMA practices have changed over the past 6 years and whether there is variation in use by patient, provider, and facility characteristics. METHODS: Our study population includes all patients undergoing surgery with general anesthesia at 1 of 6 geographically similar hospitals in the United States between January 1, 2017 and December 31, 2022. Intraoperative pain medications were obtained from the hospital's perioperative information management system. MMA was defined as an opioid plus at least 2 other nonopioid analgesics. Frequencies, χ 2 tests (χ 2 ), range, and interquartile range (IQR) were used to describe variation in MMA practice over time, by patient and procedure characteristics, across hospitals, and across anesthesiologists. Multivariable logistic regression was conducted to understand the independent contributions of patient and procedural factors to MMA use. RESULTS: We identified 25,386 procedures among 21,227 patients. Overall, 46.9% of cases met our definition of MMA. Patients who received MMA were more likely to be younger females with a lower comorbidity burden undergoing longer and more complex procedures that included an inpatient admission. MMA use has increased steadily by an average of 3.0% each year since 2017 (95% confidence interval =2.6%-3.3%). There was significant variation in use across hospitals (n = 6, range =25.9%-68.6%, χ 2 = 3774.9, P < .001) and anesthesiologists (n = 190, IQR =29.8%-65.8%, χ 2 = 1938.5, P < .001), as well as by procedure characteristics. The most common MMA protocols contained acetaminophen plus regional anesthesia (13.0% of protocols) or acetaminophen plus dexamethasone (12.2% of protocols). During the study period, the use of opioids during the preoperative or intraoperative period decreased from 91.4% to 86.0% of cases; acetaminophen use increased (41.9%-70.5%, P < .001); dexamethasone use increased (24.0%-36.1%, P < .001) and nonsteroidal anti-inflammatory drugs (NSAIDs) increased (6.9%-17.3%, P < .001). Gabapentinoids and IV lidocaine were less frequently used but also increased (0.8%-1.6% and 3.4%-5.3%, respectively, P < .001). CONCLUSIONS: In a large integrated US health care system, approximately 50% of noncardiac surgery patients received MMA. Still, there was wide variation in MMA use by patient and procedure characteristics and across hospitals and anesthesiologists. Our findings highlight a need for further research to understand the reasons for these variations and guide the safe and effective adoption of MMA into routine practice.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Graham LA, Illarmo SS, Wren SM, et al. Variations in Current Practice and Protocols of Intraoperative Multimodal Analgesia: A Cross-Sectional Study Within a Six-Hospital US Health Care System. Anesth Analg. 2024. PMID: 39453849. doi:10.1213/ANE.0000000000007299

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。